Nanobiotix S.A. (ADR)
General ticker "NBTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $328.6M (TTM average)
Nanobiotix S.A. (ADR) follows the US Stock Market performance with the rate: 47.5%.
Estimated limits based on current volatility of 2.6%: low 20.45$, high 21.55$
Factors to consider:
- Total employees count: 88 as of 2020
Short-term NBTX quotes
Long-term NBTX plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €4.78MM | €36.21MM | €0.00MM |
| Operating Expenses | €51.48MM | €62.99MM | €68.39MM |
| Operating Income | €-46.70MM | €-26.78MM | €-68.39MM |
| Non-Operating Income | €-10.33MM | €-12.80MM | €0.36MM |
| Interest Expense | €5.84MM | €7.98MM | €8.09MM |
| R&D Expense | €32.64MM | €38.40MM | €40.54MM |
| Income(Loss) | €-57.03MM | €-39.58MM | €-68.03MM |
| Taxes | €0.01MM | €0.12MM | €0.10MM |
| Profit(Loss)* | €-57.05MM | €-39.70MM | €-68.13MM |
| Stockholders Equity | €-27.05MM | €-1.84MM | €-65.70MM |
| Inventory | €2.98MM | €0.20MM | €0.00MM |
| Assets | €59.77MM | €93.90MM | €67.42MM |
| Operating Cash Flow | €-37.10MM | €-12.48MM | €-19.55MM |
| Capital expenditure | €0.09MM | €0.34MM | €0.85MM |
| Investing Cash Flow | €0.14MM | €-0.35MM | €-0.95MM |
| Financing Cash Flow | €-5.65MM | €46.77MM | €-5.13MM |
| Earnings Per Share** | €-1.64 | €-1.08 | €-1.44 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.